Literature DB >> 19759002

The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein.

S Fabio Falsone1, Andreas J Kungl, Angelika Rek, Roberto Cappai, Klaus Zangger.   

Abstract

Alpha-synuclein is an intrinsically unstructured protein that binds to membranes, forms fibrils, and is involved in neurodegeneration. We used a reconstituted in vitro system to show that the molecular chaperone Hsp90 influenced alpha-synuclein vesicle binding and amyloid fibril formation, two processes that are tightly coupled to alpha-synuclein folding. Binding of Hsp90 to monomeric alpha-synuclein occurred in the low micromolar range, involving regions of alpha-synuclein that are critical for vesicle binding and amyloidogenesis. As a consequence, both processes were affected. In the absence of ATP, the accumulation of non-amyloid alpha-synuclein oligomers prevailed over fibril formation, whereas ATP favored fibril growth. This suggests that Hsp90 modulates the assembly of alpha-synuclein in an ATP-dependent manner. We propose that Hsp90 affects these folding processes by restricting conformational fluctuations of alpha-synuclein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759002      PMCID: PMC2781518          DOI: 10.1074/jbc.M109.057240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Authors:  H LeVine
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates.

Authors:  Chunjuan Huang; Han Cheng; Shufeng Hao; Hui Zhou; Xujia Zhang; Jianen Gao; Qi-Hong Sun; Hongyu Hu; Chih-Chen Wang
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

3.  Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.

Authors:  L Narhi; S J Wood; S Steavenson; Y Jiang; G M Wu; D Anafi; S A Kaufman; F Martin; K Sitney; P Denis; J C Louis; J Wypych; A L Biere; M Citron
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Conformational properties of alpha-synuclein in its free and lipid-associated states.

Authors:  D Eliezer; E Kutluay; R Bussell; G Browne
Journal:  J Mol Biol       Date:  2001-04-06       Impact factor: 5.469

7.  A novel HSP90 chaperone complex regulates intracellular vesicle transport.

Authors:  Gregor P Lotz; Alexander Brychzy; Stefan Heinz; Wolfgang M J Obermann
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

8.  Unique copper-induced oligomers mediate alpha-synuclein toxicity.

Authors:  Josephine A Wright; Xiaoyan Wang; David R Brown
Journal:  FASEB J       Date:  2009-03-26       Impact factor: 5.191

9.  The intrinsically disordered TC-1 interacts with Chibby via regions with high helical propensity.

Authors:  Chris Gall; Hanyu Xu; Anne Brickenden; Xuanjun Ai; Wing Yiu Choy
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

10.  Formation of toxic oligomeric alpha-synuclein species in living cells.

Authors:  Tiago Fleming Outeiro; Preeti Putcha; Julie E Tetzlaff; Robert Spoelgen; Mirjam Koker; Filipe Carvalho; Bradley T Hyman; Pamela J McLean
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  41 in total

1.  Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.

Authors:  Samantha Pemberton; Karine Madiona; Laura Pieri; Mehdi Kabani; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  Q-bodies monitor the quinary state of the protein fold.

Authors:  Daniela Martino Roth; William E Balch
Journal:  Nat Cell Biol       Date:  2013-10       Impact factor: 28.824

4.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

5.  Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model.

Authors:  Hongrong Xie; Hui Hu; Ming Chang; Dongya Huang; Xiaobo Gu; Xinli Xiong; Ran Xiong; Linsen Hu; Gang Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

6.  Mechanistic basis for the recognition of a misfolded protein by the molecular chaperone Hsp90.

Authors:  Javier Oroz; Jin Hae Kim; Bliss J Chang; Markus Zweckstetter
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

Review 7.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 8.  Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

Authors:  Herman van der Putten; Gregor P Lotz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 9.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

10.  Heat shock protein 90 in neurodegenerative diseases.

Authors:  Wenjie Luo; Weilin Sun; Tony Taldone; Anna Rodina; Gabriela Chiosis
Journal:  Mol Neurodegener       Date:  2010-06-03       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.